{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:06:07Z","timestamp":1790863567868,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.intimp.2004.11.006","type":"journal-article","created":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T12:34:00Z","timestamp":1107261240000},"page":"591-599","source":"Crossref","is-referenced-by-count":54,"title":["Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"5","author":[{"given":"Shen-An","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian L.","family":"Kruzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey K.","family":"Actor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2004.11.006_bib1","series-title":"The world health report 2003","article-title":"Global tuberculosis control. Surveillance, planning, financing","author":"World Health Organization","year":"2003"},{"key":"10.1016\/j.intimp.2004.11.006_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tube.2003.08.010","article-title":"Immunology of tuberculosis and implications in vaccine development","volume":"84","author":"Flynn","year":"2004","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.intimp.2004.11.006_bib3","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0171-2985(11)80459-6","article-title":"Experimental approaches to mechanisms of protection and pathogenesis in M. tuberculosis infection","volume":"191","author":"Bloom","year":"1994","journal-title":"Immunobiology"},{"key":"10.1016\/j.intimp.2004.11.006_bib4","series-title":"Vaccines: preventing disease & preventing health","first-page":"177","article-title":"A new generation of tuberculosis vaccine","author":"Brennan","year":"2004"},{"key":"10.1016\/j.intimp.2004.11.006_bib5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00011-004-1257-1","article-title":"Protective effects of lactoferrin in Escherichia coli-induced bacteremia in mice: relationship to reduced serum TNF alpha level and increased turnover of neutrophils","volume":"53","author":"Zimecki","year":"2004","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.intimp.2004.11.006_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/B:BIOM.0000027696.48707.42","article-title":"Lactoferrin and host defense: an overview of its immuno-modulating and anti-inflammatory properties","volume":"17","author":"Legrand","year":"2004","journal-title":"Biometals"},{"key":"10.1016\/j.intimp.2004.11.006_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2249.2002.01956.x","article-title":"Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice","volume":"130","author":"Kruzel","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2004.11.006_bib8","first-page":"169","article-title":"Lactoferrin effects on the in vitro immune response in critically ill patients","volume":"46","author":"Adamik","year":"1998","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"10.1016\/j.intimp.2004.11.006_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1139\/o01-228","article-title":"Characterization of mammalian receptors for lactoferrin","volume":"80","author":"Suzuki","year":"2002","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.intimp.2004.11.006_bib10","first-page":"399","article-title":"Lactoferrin and immunologic dissonance: clinical implications","volume":"50","author":"Kruzel","year":"2002","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"10.1016\/j.intimp.2004.11.006_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0165-2478(00)00260-1","article-title":"Systemic or local co-administration of lactoferrin with sensitizing dose of antigen enhances delayed type hypersensitivity in mice","volume":"74","author":"Zimecki","year":"2000","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2004.11.006_bib12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1567-5769(01)00189-8","article-title":"Lactoferrin immunomodulation of DTH response in mice","volume":"2","author":"Actor","year":"2002","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2004.11.006_bib13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1365-3083.2001.00902.x","article-title":"A role for complement C5 in organism containment and granulomatous response during murine tuberculosis","volume":"53","author":"Actor","year":"2001","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.intimp.2004.11.006_bib14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/S0882-0546(03)00068-9","article-title":"TB vaccines at the turn of the century: insights into immunity to M. tuberculosis and modern approaches for prevention of an ancient disease","volume":"18","author":"Lewinsohn","year":"2003","journal-title":"Semin. Respir. Infect."},{"issue":"Suppl. 3","key":"10.1016\/j.intimp.2004.11.006_bib15","doi-asserted-by":"crossref","first-page":"S316","DOI":"10.1086\/313881","article-title":"Potential impact of tuberculosis vaccines as epidemic control agents","volume":"30","author":"Lietman","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.intimp.2004.11.006_bib16","doi-asserted-by":"crossref","first-page":"13881","DOI":"10.1073\/pnas.95.23.13881","article-title":"Modeling the impact of global tuberculosis control strategies","volume":"95","author":"Murray","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2004.11.006_bib17","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1073\/pnas.091096998","article-title":"Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha\/beta","volume":"98","author":"Manca","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2004.11.006_bib18","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.271.9.698","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2004.11.006_bib19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1182\/blood.V80.1.235.235","article-title":"Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin","volume":"80","author":"Crouch","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2004.11.006_bib20","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1128\/IAI.66.2.486-491.1998","article-title":"Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein","volume":"66","author":"Elass-Rochard","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2004.11.006_bib21","doi-asserted-by":"crossref","first-page":"723","DOI":"10.4049\/jimmunol.146.2.723","article-title":"Lactoferrin\u2013lipopolysaccharide interactions. Effect on lactoferrin binding to monocyte\/macrophage-differentiated HL-60 cells","volume":"146","author":"Miyazawa","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2004.11.006_bib22","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4049\/jimmunol.168.3.1322","article-title":"Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present","volume":"168","author":"Cooper","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2004.11.006_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1084\/jem.186.1.39","article-title":"Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis","volume":"186","author":"Cooper","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2004.11.006_bib24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0020-7519(03)00061-4","article-title":"Recent progress in the development and testing of vaccines against human tuberculosis","volume":"33","author":"McMurray","year":"2003","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.intimp.2004.11.006_bib25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tube.2003.08.011","article-title":"Approaches towards the development of a vaccine against tuberculosis: recombinant BCG and DNA vaccine","volume":"84","author":"Nor","year":"2004","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.intimp.2004.11.006_bib26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1586\/14760584.1.3.341","article-title":"Tuberculosis vaccines: the past, present and future","volume":"1","author":"Wang","year":"2002","journal-title":"Expert. Rev. Vaccines"},{"key":"10.1016\/j.intimp.2004.11.006_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/713608013","article-title":"How far have we reached in tuberculosis vaccine development?","volume":"29","author":"Kumar","year":"2003","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.intimp.2004.11.006_bib28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1046\/j.1440-1711.2000.00937.x","article-title":"New tuberculosis vaccines based on attenuated strains of the Mycobacterium tuberculosis complex","volume":"78","author":"Collins","year":"2000","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.intimp.2004.11.006_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1473-3099(01)00018-4","article-title":"Prospects for better tuberculosis vaccines","volume":"1","author":"Collins","year":"2001","journal-title":"Lancet, Infect. Dis."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576904003637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576904003637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T22:49:24Z","timestamp":1682981364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576904003637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S1567576904003637"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2004.11.006","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}